About

Gynica is a biotech company driven to improve the lives of hundreds of millions of women worldwide suffering from Endometriosis, by providing safe, effective, non-hormonal, intra-vaginal therapeutic solutions.

Gynica’s IntraVag© is a proprietary microencapsulation technology designed for controlled-release of APIs directly to the vaginal cavity. This non-invasive, self-administered method ensures maximum efficacy while minimizing systemic absorption and potential side effects.

IntraVag© harness the therapeutic properties of cannabinoids. While there is a lack of comprehensive scientific studies and clinical data in the fields of cannabinoids and women’s health, studies suggest a link between women with Endometriosis and an endocannabinoid deficiency (2), highlighting the potential for cannabinoids to provide relief from Endometriosi (3) associated symptoms. Gynica bridges this knowledge gap through novel scientific studies resulting in pioneering advancements to improve the well-being and quality of life for millions of women worldwide.